{"id":"W3164862257","doi":"10.1016/j.xfre.2021.05.004","title":"Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis","year":2021,"lang":"en","type":"article","venue":"F&S Reports","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Agency for Healthcare Research and Quality; AbbVie","keywords":"Adenomyosis; Medicine; Clinical endpoint; Placebo; Uterine fibroids; Adverse effect; Gynecology; Confidence interval; Internal medicine; Randomized controlled trial; Obstetrics; Urology; Uterus; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001850973,0.000125768,0.0003748619,0.0001171773,0.00003010426,0.00001554197,0.00001544312,0.00003462911,0.0002047029],"category_scores_gemma":[0.0002214336,0.00008042371,0.00001392792,0.0003828491,0.00009059643,0.00004554961,0.00003865323,0.0001046726,5.792828e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006394978,"about_ca_system_score_gemma":0.0001476731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009787259,"about_ca_topic_score_gemma":0.00005039131,"domain_scores_codex":[0.9988896,0.00003538225,0.0002730252,0.0002933276,0.0002671902,0.0002414506],"domain_scores_gemma":[0.9991378,0.0002095739,0.0001066541,0.0002609132,0.0001057489,0.0001793147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009594788,0.0008596477,0.8494667,0.0005056238,0.0006641834,0.01649053,0.001669065,0.000009719456,0.007604888,0.00001034348,0.0001050046,0.1130195],"study_design_scores_gemma":[0.01095315,0.004247343,0.9570042,0.0006689116,0.00002475715,0.004361617,0.0003256573,0.000007157724,0.01159341,0.00001465512,0.01065461,0.0001445265],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956994,0.001914862,0.00001236573,0.0002382236,0.000007291385,0.0004226493,0.000005569596,0.00001057812,0.001689077],"genre_scores_gemma":[0.9955988,0.001829351,0.00174882,0.00004383809,0.00002014161,0.00003296889,0.00001970191,0.00001700483,0.0006893753],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.112875,"threshold_uncertainty_score":0.3279583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01944268618455314,"score_gpt":0.3009481062799821,"score_spread":0.281505420095429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}